MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

An Analysis of Health Care Utilization in Functional Movement Disorders: Does Diagnosis Make a Difference?

K. Kyle, A. Wu, F. Agosta (Los Angeles, CA, USA)

Meeting: MDS Virtual Congress 2020

Abstract Number: 327

Keywords: Psychogenic movement disorders(PMD): Clinical features

Category: Other

Objective: To investigate the impact of diagnosis on health care utilization (HCU) in the functional movement disorders (FMD) population.

Background: FMD patients are considered to be high health care utilizers, to an extent that has been described as a crisis.1 Functional neurologic presentations may represent up to 30% of cases in neurology clinic.2 Current expert opinion is that delivery of FMD diagnosis is a key part of the therapeutic process.3 There is a paucity of data on whether expert diagnosis of FMD affects health care utilization . We hypothesize that clear delivery of diagnosis by movement disorder specialists reduces health care utilization.

Method: This was a retrospective analysis of HCU in patients diagnosed with predominant FMD in the UCLA Movement Disorders clinics between January 2014 until December 2018. Cases were identified by ICD10 codes and validated by chart review using diagnostic criteria (adapted from Lang/Gupta).4 We included patients who were diagnosed with FMD (Dx) or FMD was high on a differential diagnoses (DDx) and who received follow-up at UCLA. We assessed frequency of outpatient, inpatient, emergency, imaging and procedure encounters as HCU measures for 12 months before and after diagnosis date.

Results: Of 42 patients with validated FMD Dx or DDx, 18 patients (14 female, mean age 51.6 [16-92 range]) received follow-up care and were analyzed. We found a significant decrease in imaging studies (mean 4.9 pre-dx, 2.8 post-dx, p=0.005) and no significant changes in outpatient visits (7.9 pre-dx, 10.0 post-dx, p=0.48); procedures (1.55 pre, 2.83 post, p=0.37); patient messages (10.6 pre, 11.2 post, p=0.87). There were very few emergency room (ER) and hospital encounters with no significant differences (combined 1.06 pre, 0.56 post, p=0.25). Among 13 patients who received advice about psychotherapy, we found a significant decrease in ER/hospital visits (1.08 pre, 0.15 post, p=0.046).

Conclusion: Results suggest that a clear FMD diagnosis or presentation of FMD as a viable differential diagnosis in a tertiary movement disorders clinic may reduce imaging utilization. Further, recommendations for psychotherapy may contribute to reduction of hospital and ER utilization. This study is limited by small sample size at a single institution, by excluding patients who did not follow-up at our institution and by information available only from our institutional electronic health record.

References: 1. Hallett, M. Psychogenic movement disorders: A crisis for neurology. Curr. Neurol. Neurosci. Rep. 6, 269–271 (2006). 2. Evens, A., Vendetta, L., Krebs, K. & Herath, P. Medically Unexplained Neurologic Symptoms: A Primer for Physicians Who Make the Initial Encounter. Am. J. Med. 128, 1059–1064 (2015). 3. Stone, J., Carson, A. & Hallett, M. Explanation as treatment for functional neurologic disorders. in Handbook of Clinical Neurology (2016). doi:10.1016/B978-0-12-801772-2.00044-8 4. Gupta, A. & Lang, A. E. Psychogenic movement disorders. Curr. Opin. Neurol. 22, 430–6 (2009).

To cite this abstract in AMA style:

K. Kyle, A. Wu, F. Agosta. An Analysis of Health Care Utilization in Functional Movement Disorders: Does Diagnosis Make a Difference? [abstract]. Mov Disord. 2020; 35 (suppl 1). https://www.mdsabstracts.org/abstract/an-analysis-of-health-care-utilization-in-functional-movement-disorders-does-diagnosis-make-a-difference/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to MDS Virtual Congress 2020

MDS Abstracts - https://www.mdsabstracts.org/abstract/an-analysis-of-health-care-utilization-in-functional-movement-disorders-does-diagnosis-make-a-difference/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley